Search Results
Jun 03, 2026, 01:30 ET Factorial Raises $150M Series D, Reaches $2.5 Billion Valuation to Become One of the Most Valuable AI Scale-Ups in Europe
General Catalyst leads $150M equity investment, its first equity stake in Factorial as part of Series D round that values the company at over $2.5 billion, becoming one of the most valuable AI scale-ups in EuropeGeneral Catalyst simultaneously commits an additional $540M
More news about: Team Lewis Barcelona
Jun 03, 2026, 01:30 ET Factorial erhält 150 Mio. US-Dollar in Series-D-Finanzierung und erreicht Bewertung von 2,5 Mrd. US-Dollar - eines der wertvollsten KI-Scale-ups Europas
General Catalyst führt das 150-Mio.-US-Dollar-Eigenkapitalinvestment an, übernimmt im Rahmen der Series-D-Runde erstmals einen direkten Anteil an Factorial und bewertet das Unternehmen mit über 2,5 Mrd. US-Dollar. Factorial wird damit zu einem der wertvollsten KI-Scale-ups Europas.General Catalyst stellt gleichzeitig weitere 540 Mio. US-Dollar über seinen Customer
More news about: Team Lewis Barcelona
Jun 03, 2026, 01:30 ET Factorial capta 150 millones de dólares en una Serie D y alcanza una valoración de 2.500 millones, situándose entre las scale-ups de IA más valiosas de España
/PRNewswire/ -- Factorial, la principal plataforma europea de IA para la gestión de equipos, ha anunciado hoy el cierre de una ronda de financiación de Serie D de 150 millones de dólares, que valora la compañía en 2.500 millones de dólares situándola entre las scale-ups más valiosas de España y de Europa.
More news about: Team Lewis Barcelona
Jun 03, 2026, 01:30 ET Factorial lève 150 M$ en série D et atteint une valorisation de 2,5 milliards de dollars pour devenir l'une des scale-ups IA les mieux valorisées en Europe
General Catalyst annonce un investissement de 150 M$ au capital, sa première participation au capital de Factorial dans le cadre de ce tour de série D. Ce nouveau tour valorise l'entreprise à plus de 2,5 milliards de dollars, faisant d'elle l'une des scale-ups IA les mieux valorisées en Europe.General
More news about: Team Lewis Barcelona
Jun 03, 2026, 01:30 ET AZ8 Launches AZ8 Theater to Showcase AI-Native Storytelling and Emerging Creators
audio, 3D scenes, and AI models together, while AZ8 Theater gives emerging creators and original stories a place to be discovered." At the center of AZ8's creation ecosystem is its canvas-based workflow. Instead of switching between disconnected tools for text, image, video, audio, 3D scenes,
More news about: AZ8
Jun 03, 2026, 01:18 ET Una ciudad del sureste de China abre un nuevo espacio para el comercio de prendas de vestir y calzado
motivos tradicionales del sur de Fujian, ayudaron a los productores locales a desarrollar sus propios estilos.Mientras tanto, sus capacidades de I+D siguen mejorando y siguen apareciendo nuevos tejidos para ropa deportiva, junto con una gama de productos más amplia en deportes profesionales, actividades
More news about: Xinhua Silk Road
Jun 03, 2026, 01:00 ET Quobly secures €115 million Series A to bring silicon-based quantum computers to market
Deep Tech 2030 fund, managed on behalf of the French government as part of the France 2030 initiative.This financing will support continued R&D, industrialization efforts and international commercial expansion.Quobly, bringing semiconductor-grade manufacturing and industrialization
More news about: Quobly
Jun 03, 2026, 01:00 ET Quobly secures €115 million Series A to bring silicon-based quantum computers to market
Deep Tech 2030 fund, managed on behalf of the French government as part of the France 2030 initiative.This financing will support continued R&D, industrialization efforts and international commercial expansion.Quobly, bringing semiconductor-grade manufacturing and industrialization
More news about: Quobly
Jun 03, 2026, 00:04 ET Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study
(or equivalent) dose ≤7.5 mg daily; and (5) well-tolerated standard maintenance doses of immunosuppressive drugs and approved biological agents. d. Protocol-permitted background medications include oral corticosteroids, antimalarials and no more than two of the following immunomodulatory drugs: azathioprine,
More news about: Johnson & Johnson
Jun 03, 2026, 00:03 ET Johnson & Johnson presents new data further reinforcing the role of nipocalimab in lowering the autoantibodies driving Sjögren's disease
been compensated for any media work.d.ClinESSDAI is an endpoint specific to SjD and is a
More news about: Johnson & Johnson
Jun 03, 2026, 00:01 ET In Every Region of the U.S., Mothers are Living In Maternal Red Flag Zones: New Data Maps Communities Where Risks are Highest
financial edge. Up to 308 rural hospitals are at risk of closure in 2026. In states with the highest MVI scores, 104 rural hospitals and 35 rural L&D units face potential closure, in the communities that can least afford to lose them. (Source:
More news about: Surgo Health, PBC
Jun 03, 2026, 00:00 ET Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026
cancer), ALPPL2 x CD3 (ATG-112 for gynecological tumors, digestive system malignancies, bladder cancer and NSCLC), LY6G6D x CD3 (ATG-110 for microsatellite-stable colorectal cancer), GPRC5D x CD3 (ATG-021 for multiple myeloma), LILRB4 x CD3 (ATG-102 for acute myeloid leukemia and chronic myelomonocytic leukemia)
More news about: Antengene Corporation Limited
Jun 02, 2026, 23:23 ET G700 se lanza en México y JETOUR acelera su expansión en el mercado de vehículos todoterreno premium de Latinoamérica
premium de vehículos todoterreno de Latinoamérica. De cara al futuro, JETOUR reforzará aún más su presencia en Latinoamérica mediante el impulso de I+D a nivel local y la entrega de productos y servicios de mayor calidad a los consumidores de la región.Contacto:Tina LiuJETOUR Auto+86-13757229826
More news about: JETOUR AUTO
Jun 02, 2026, 22:35 ET WuXi Biologics Named to CDP Supplier Engagement Assessment A List for the Second Consecutive Year
worldwide*.With over 13,000 employees in China, the United States, Ireland, Germany, and Singapore — including experts and scientists in biologics R&D and manufacturing, technology innovation, and operational excellence — WuXi Biologics leverages its technologies and expertise to deliver efficient,
More news about: WuXi Biologics
Jun 02, 2026, 21:00 ET GIGABYTE EVENT、COMPUTEX 2026で「無限へ（ENTER INFINITY）」を掲げ新製品群を一挙発表
計されたINFINITYシリーズです。マザーボードでは、X870 AORUS INFINITYが、最大11,400MT/sの速度とCL24低レイテンシーチューニングにより応答性を最大20%高速化し、DDR5性能を再定義します。さらに、AMD Ryzen™ 9 9950X3D2プロセッサーの潜在能力をインテリジェントに最大限引き出すX3D Turbo Mode 2.0も搭載しています。X870E AORUS INFINITY NEXTは、業界初の3Dメタルプリント冷却部品と、AIおよび高性能ワークロード向けに、より高い熱効率と持続的な安定性を実現する宇宙グレードの電源供給設計Quad OptiMOSを採用しています。INFINITYシリーズはPCビルド全体に対応し、独自のWINDFORCE
More news about: GIGABYTE
Jun 02, 2026, 21:00 ET 기가바이트, 컴퓨텍스 2026에서 AORUS K10 INFINITY 키보드와 M10 INFINITY 마우스로 차세대 게이밍 주변기기 공개
multimedia:https://www.prnewswire.com/kr/news-releases/uAE30uAC00uBC14uC774uD2B8u002Cu002DuCEF4uD4E8uD14DuC2A4u002Du0032u0030u0032u0036uC5D0uC11Cu002Du0061u006Fu0072u0075u0073u002Du006Bu0031u0030-302786996.htmlSOURCE
More news about: GIGABYTE
Jun 02, 2026, 20:00 ET Kelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at ASCO 2026
China.About Kelun-BiotechKelun-Biotech (6990.HK) is a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of innovative biological drugs and small molecule drugs. Kelun-Biotech focuses on major
More news about: Kelun-Biotech
Jun 02, 2026, 19:17 ET DXC lança um de seus mais poderosos motores de crescimento: o DXC Engineering
DNA singular de engenharia da DXC. Estamos nos estágios iniciais da era definida por software, e este é o momento para que os clientes transformem P&D em sistemas inteligentes definidos por software capazes de ajudá-los a vencer no mercado. O DXC Engineering é um sinal para o mercado e para nossos
More news about: DXC Technology Company
Jun 02, 2026, 19:02 ET DXC, 가장 강력한 성장 엔진 중 하나인 DXC 엔지니어링 출시
multimedia:https://www.prnewswire.com/kr/news-releases/u0064u0078u0063u002Cu002DuAC00uC7A5u002DuAC15uB825uD55Cu002DuC131uC7A5u002DuC5D4uC9C4u002DuC911u002DuD558uB098uC778u002Du0064u0078u0063u002D-302789342.htmlSOURCE
More news about: DXC Technology Company
Jun 02, 2026, 19:00 ET Reach Surgical Receives CE Mark Approval for SOUND REACH™ Swift
supporting healthcare providers in delivering quality care and enabling more patients to benefit from medical advances. With integrated capabilities from R&D and manufacturing to commercialisation, Genesis MedTech builds on a strong foundation of quality, training and education, serving surgical, cardiology,
More news about: Genesis MedTech Group
Jun 02, 2026, 18:52 ET DXC lance l'un de ses principaux moteurs de croissance : DXC Engineering
DXC. Nous en sommes aux prémices de l'ère des systèmes définis par logiciel, et le moment est venu pour les clients de transformer leurs activités de R&D en systèmes intelligents définis par logiciel qui leur permettront de s'imposer sur le marché. DXC Engineering montre ainsi au marché et à nos clients
More news about: DXC Technology Company
Jun 02, 2026, 18:49 ET Daubert Cromwell Launches World's First 100% Anaerobically Biodegradable and Recyclable VCI Films with BioNatur® Technology
management infrastructure.Meeting Regulatory and Industry StandardsThe films meet the EU Directive on Packaging and Packaging Waste, with ASTM D5511 biodegradability testing demonstrating 99.7% biodegradation in under five years (as long as this newly developed additive has been in testing)
More news about: Daubert Cromwell
Jun 02, 2026, 18:48 ET DXC lanza uno de sus motores de crecimiento más potentes: DXC Engineering
encontramos en las primeras etapas de la era definida por el software, y ha llegado el momento de que los clientes conviertan la Investigación y Desarrollo (I+D) en sistemas inteligentes definidos por software que los ayuden a tener éxito en el mercado. DXC Engineering es una señal para el mercado y para nuestros
More news about: DXC Technology Company
Jun 02, 2026, 18:19 ET DriveNets obtient 410 millions de dollars dans le cadre d'une série D pour répondre à la demande croissante pour des structures Ethernet dans les déploiements d'IA à grande échelle
DriveNets, un leader des solutions de mise en réseau à grande échelle, annonce aujourd'hui avoir achevé un tour de financement de série D de 410 millions de dollars, atteignant ainsi le milliard de dollars de capital total levé. Avec plus d'un milliard de dollars de capital levé et un flux
More news about: Drivenets Ltd.
Jun 02, 2026, 17:59 ET MAHA Center Launches National Chiropractic Hub to Champion Drug-Free, Prevention-First Care
https://www.logan.edu/wp-content/uploads/2021/07/Chiropractic-services-and-opioid-utilization_Whedon.pdf[2] Keeney BJ, Fulton-Kehoe D, Turner JA, Wickizer TM, Chan KC, Franklin GM. "Early Predictors of Lumbar Spine Surgery after Occupational Back Injury: Results from a Prospective Study
More news about: MAHA Center Inc.